Company / Gross Margin
Insulet Corporation Gross Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
71.6%
FY2025
5-year range
61.7% / 71.6%
FY2021-FY2025
Trend
+2.6%
vs FY2024
Sector context
#15 of 91
Health Care
What the data says
Insulet Corporation's gross margin of 71.6% is higher than 84% of companies in the Health Care sector (FY2025). Gross Margin has increased for 3 consecutive years, from 61.7% in FY2022 to 71.6% in FY2025.
Based on SEC 10-K filings.
71.6% in FY2025 with a 5-year CAGR of +7.2%. Top quartile in the Health Care sector.
Improved from 68.3% to 71.6% over the past 2 years.
Health Care sector context is included.
Gross Margin over time
Growth rates
- 3-Year Change
- +9.9pp
- 5-Year Change
- +7.2pp
- 10-Year Change
- -
Sector benchmark
Top 16% in Health CareTop 16% of 91This company 71.6% Sector average 53.8%
▼
+33.2% above sector average
Key checks
Key Insights
- Insulet Corporation's gross margin has grown for 3 consecutive years.
- In FY2025, gross margin increased 2.6% year-over-year.
- Currently 17.8pp above the Health Care sector average.
- Lowest gross margin in the period was in FY2016.
Company context
Key Data Points
- Strong profit margin: 20.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 71.6% | +2.6% |
| FY2024 | 69.8% | +2.1% |
| FY2023 | 68.3% | +10.7% |
| FY2022 | 61.7% | -9.8% |
| FY2021 | 68.5% | +6.3% |
| FY2020 | 64.4% | -1.0% |
| FY2019 | 65.1% | -0.9% |
| FY2018 | 65.7% | +9.9% |
| FY2017 | 59.8% | +3.9% |
| FY2016 | 57.5% | +13.9% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026